Riskpilot← Back to searchSign inGet full accessReiBeck Innovation AB
ABActiveOrg 5594564899Nummerjordsgränd 6 CWholesale of pharmaceutical and medical goods · NACE 4646Est. 20230 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -8K
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -8K | — |
| Net profit | SEK -8K | — |
| Total assets | SEK 17K | — |
| Equity | SEK 17K | — |
| Employees | 0 | — |
Legal name
ReiBeck Innovation AB
Org number
5594564899
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 november 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska utveckla, konstruera och tillhandahålla samt försälja medicinsk utrustning eller läkemedel för behandling av olika sjukdomstillstånd, framför allt i luftvägarna samt därmed förenlig verksamhet.
Address
Nummerjordsgränd 6 C
Email
akereimer@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 0 |
| Staff expenses | −0 |
| EBITDA | −8 |
| Depreciation & amort. | — |
| EBIT | −8 |
| Net financials | — |
| Profit before tax | −8 |
| Tax | — |
| Net profit | −8 |
| Item | 2024 |
|---|---|
| Total assets | 17 |
| Equity | 17 |
| Long-term debt | — |
| Short-term debt | — |
| Total debt | — |
EBITDA margin
-759200.0%
This company
15.8%
Market median
-4805163% vs market
20242024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20242024
Return on equity
-43.6%
This company
18.4%
Market median
-337% vs market
20242024
Net profit margin
-759200.0%
This company
8.1%
Market median
-9372940% vs market
20242024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20242024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ÅR Chief Executive Officer | Chief Executive Officer | 2025 |
CM Chief Auditor | Chief Auditor | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2023 | |
| Deputy Board Member | 2023 | |
| Chairman | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ReiBeck Innovation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åke Reimer | Chief Executive Officer | 0 companies |
| Carl Magnus Haak | Chief Auditor | 0 companies |
| Anna Blom | Deputy Board Member | 0 companies |
| Kirsti Hillevi Kvarnerot Reimer | Deputy Board Member | 0 companies |
| Gert Gunnar Kristian Riesbeck | Chairman | 0 companies |